Literature DB >> 25564132

Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013.

Hélène Verdoux1,2,3, Elodie Pambrun4,5, Sébastien Cortaredona6,7, Marie Tournier4,5,8, Pierre Verger6,7.   

Abstract

The objectives were to explore in a community-based sample of persons aged 0-25 years: (1) trends in antipsychotic prescribing, (2) characteristics of the zone of residence associated with antipsychotic prescribing rates, and (3) the pattern of antipsychotic prescribing. The study was performed using reimbursement data from the French Insurance Healthcare system. Prescribing trends were investigated over the period 2006-2013. An ecological design was used to assess the impact of the socio-economical and health resource characteristics of the zone of residence (n = 96 administrative subdivisions of French territory) on antipsychotic prescribing rates. The pattern of antipsychotic prescribing was explored in a cohort of youths newly treated with antipsychotics. Over the period 2006-2013, antipsychotic dispensing rates were stable in persons aged 0-25 years (4.8 per 1,000 in 2006 and 4.9 per 1,000 in 2013). First-generation antipsychotic dispensing rates decreased from 3.1 to 2.6 per 1,000 (OR = 0.96, 95% CI 0.94-0.98), while second-generation antipsychotic dispensing rates increased from 2.7 to 3.4 per 1,000 (OR = 1.03, 95% CI 1.01-1.05). Antipsychotic prescribing rates were impacted by health resource characteristics of the zone of residence in children aged 10 years and under and by socio-economical characteristics in those aged 16-20 years. In all the age groups, antipsychotics were principally started by hospital practitioners (47%) and general practitioners (34%). The rates of psychostimulants concomitantly prescribed with antipsychotics were lower than 5%. In conclusion, rates of youths exposed to second-generation antipsychotics are still rising. The impact of environmental characteristics on antipsychotics prescribing and appropriateness of these prescriptions in youths should be further investigated.

Entities:  

Keywords:  Adolescents; Antipsychotics; Children; Community characteristics; Prescribing trends

Mesh:

Substances:

Year:  2015        PMID: 25564132     DOI: 10.1007/s00787-014-0668-y

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  48 in total

1.  Multiple outputation: inference for complex clustered data by averaging analyses from independent data.

Authors:  Dean Follmann; Michael Proschan; Eric Leifer
Journal:  Biometrics       Date:  2003-06       Impact factor: 2.571

2.  National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

Authors:  Mark Olfson; Carlos Blanco; Linxu Liu; Carmen Moreno; Gonzalo Laje
Journal:  Arch Gen Psychiatry       Date:  2006-06

3.  Psychotropic co-medication among stimulant-treated children in The Netherlands.

Authors:  Adrianne Faber; Lolkje T W de Jong-van den Berg; Paul B van den Berg; Hilde Tobi
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-02       Impact factor: 2.576

4.  French national health insurance information system and the permanent beneficiaries sample.

Authors:  P Tuppin; L de Roquefeuil; A Weill; P Ricordeau; Y Merlière
Journal:  Rev Epidemiol Sante Publique       Date:  2010-07-03       Impact factor: 1.019

5.  Social inequalities in early antidepressant discontinuation.

Authors:  Aurélie Bocquier; Sébastien Cortaredona; Hélène Verdoux; Ludovic Casanova; Vincent Sciortino; Stève Nauleau; Pierre Verger
Journal:  Psychiatr Serv       Date:  2014-05-01       Impact factor: 3.084

6.  Transition in care in persons with antidepressant prescription in naturalistic conditions.

Authors:  Hélène Verdoux; Yoan Gaudron; Marie Tournier
Journal:  Fam Pract       Date:  2011-03-11       Impact factor: 2.267

7.  Within-Cluster Resampling for Analysis of Family Data: Ready for Prime-Time?

Authors:  Hemant K Tiwari; Amit Patki; David B Allison
Journal:  Stat Interface       Date:  2010-04-01       Impact factor: 0.582

8.  Use of antipsychotic drugs among Dutch youths between 1997 and 2005.

Authors:  Luuk J Kalverdijk; Hilde Tobi; Paul B van den Berg; Janelle Buiskool; Leonie Wagenaar; Ruud B Minderaa; Lolkje T W de Jong-van den Berg
Journal:  Psychiatr Serv       Date:  2008-05       Impact factor: 3.084

9.  Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Authors:  Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

10.  Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study.

Authors:  Andrea L Murphy; David M Gardner; Charmaine Cooke; Steve Kisely; Jean Hughes; Stan P Kutcher
Journal:  BMC Psychiatry       Date:  2013-07-27       Impact factor: 3.630

View more
  8 in total

1.  The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.

Authors:  C Rafaniello; M Sessa; F F Bernardi; M Pozzi; S Cheli; D Cattaneo; S Baldelli; M Molteni; R Bernardini; F Rossi; E Clementi; C Bravaccio; S Radice; A Capuano
Journal:  Pharmacogenomics J       Date:  2017-07-18       Impact factor: 3.550

2.  Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users.

Authors:  François Montastruc; Anne Bénard-Laribière; Pernelle Noize; Elodie Pambrun; Fabienne Diaz-Bazin; Marie Tournier; Bernard Bégaud; Antoine Pariente
Journal:  Eur J Clin Pharmacol       Date:  2018-01-06       Impact factor: 2.953

3.  Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.

Authors:  Carsten Schröder; Michael Dörks; Bianca Kollhorst; Tilo Blenk; Ralf W Dittmann; Edeltraut Garbe; Oliver Riedel
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-13       Impact factor: 4.785

4.  Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case-control study in Korea.

Authors:  Soo Min Jeon; Susan Park; Dohoon Kim; Jin-Won Kwon
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-04-07       Impact factor: 4.785

5.  Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE).

Authors:  Marie-Line Menard; Susanne Thümmler; Marianna Giannitelli; Bertrand Olliac; Olivier Bonnot; David Cohen; Florence Askenazy
Journal:  BMJ Open       Date:  2016-04-06       Impact factor: 2.692

6.  Influence of socioeconomic status on antipsychotic prescriptions among youth in France.

Authors:  Olivier Bonnot; Mélanie Dufresne; Paula Herrera; Emmanuelle Michaud; Jacques Pivette; Anicet Chaslerie; Anne Sauvaget; Caroline Vigneau
Journal:  BMC Psychiatry       Date:  2017-02-28       Impact factor: 3.630

7.  'Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study'.

Authors:  Florentia Kaguelidou; Jakob Holstiege; Tania Schink; Irene Bezemer; Elisabetta Poluzzi; Giampiero Mazzaglia; Lars Pedersen; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-20       Impact factor: 6.892

8.  Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study.

Authors:  Giuseppe Cicala; Maria A Barbieri; Vincenza Santoro; Carmela Tata; Pia V Colucci; Francesca Vanadia; Flavia Drago; Carmelita Russo; Paola M Cutroneo; Antonella Gagliano; Edoardo Spina; Eva Germanò
Journal:  Front Psychiatry       Date:  2020-03-24       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.